Dietary calcium, defective cellular Ca2+ handling, and arterial pressure control

D. A. McCarron, D. Hatton, Jean-Baptiste Roullet, C. Roullet

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The association between dietary calcium intake, calcium metabolism, and blood pressure form the basis of this review. Epidemiologic data consistently show an inverse relationship between dietary calcium and blood pressure. Clinical trials of calcium supplementation have not been as consistent in outcome. Approximately two-thirds of the supplementation studies have found a beneficial effect of calcium on blood pressure. The lack of consistency in outcome from the clinical trials relative to the epidemiological literature may be related to calcium intake. The epidemiological literature indicates an inverse relationship between calcium intake and blood pressure, with those individuals with the lowest calcium intake (<700 mg/day) having the highest blood pressure. Clinical studies utilizing patients with high baseline calcium levels (> 700 mg/day) may not see an effect of calcium supplementation on blood pressure because of a ceiling effect. Supplemental calcium appears to correct a defect in calcium handling characterized by a renal calcium leak, increased circulating parathyroid hormone, and increased intracellular calcium levels. In part, the deficit in cellular calcium homeostasis may be a consequence of abnormal calmodulin activity. Specifically, it appears that calmodulin activity is diminished in experimental hypertension and that increasing dietary calcium may improve calmodulin activity in the spontaneously hypertensive rat. The deficit in calmodulin activity has the potential to interfere with a number of cellular processes crucial to the regulation of cell function and maintenance of appropriate vascular tone. It is concluded that additional research should be directed toward understanding the ramifications of altered calmodulin activity in hypertension and the influence that dietary calcium can have on the activity of calmodulin.

Original languageEnglish (US)
Pages (from-to)937-944
Number of pages8
JournalCanadian Journal of Physiology and Pharmacology
Volume72
Issue number8
StatePublished - 1994

Fingerprint

Dietary Calcium
Arterial Pressure
Calcium
Calmodulin
Blood Pressure
Clinical Trials
Hypertension
Inbred SHR Rats
Parathyroid Hormone
Blood Vessels
Homeostasis

Keywords

  • Ca metabolism
  • Calcium channel blockers
  • Calmodulin
  • Dietary Ca
  • Hypertension

ASJC Scopus subject areas

  • Physiology
  • Pharmacology

Cite this

McCarron, D. A., Hatton, D., Roullet, J-B., & Roullet, C. (1994). Dietary calcium, defective cellular Ca2+ handling, and arterial pressure control. Canadian Journal of Physiology and Pharmacology, 72(8), 937-944.

Dietary calcium, defective cellular Ca2+ handling, and arterial pressure control. / McCarron, D. A.; Hatton, D.; Roullet, Jean-Baptiste; Roullet, C.

In: Canadian Journal of Physiology and Pharmacology, Vol. 72, No. 8, 1994, p. 937-944.

Research output: Contribution to journalArticle

McCarron, DA, Hatton, D, Roullet, J-B & Roullet, C 1994, 'Dietary calcium, defective cellular Ca2+ handling, and arterial pressure control', Canadian Journal of Physiology and Pharmacology, vol. 72, no. 8, pp. 937-944.
McCarron, D. A. ; Hatton, D. ; Roullet, Jean-Baptiste ; Roullet, C. / Dietary calcium, defective cellular Ca2+ handling, and arterial pressure control. In: Canadian Journal of Physiology and Pharmacology. 1994 ; Vol. 72, No. 8. pp. 937-944.
@article{133f5c36369d4a8d8519e1683d4f5095,
title = "Dietary calcium, defective cellular Ca2+ handling, and arterial pressure control",
abstract = "The association between dietary calcium intake, calcium metabolism, and blood pressure form the basis of this review. Epidemiologic data consistently show an inverse relationship between dietary calcium and blood pressure. Clinical trials of calcium supplementation have not been as consistent in outcome. Approximately two-thirds of the supplementation studies have found a beneficial effect of calcium on blood pressure. The lack of consistency in outcome from the clinical trials relative to the epidemiological literature may be related to calcium intake. The epidemiological literature indicates an inverse relationship between calcium intake and blood pressure, with those individuals with the lowest calcium intake (<700 mg/day) having the highest blood pressure. Clinical studies utilizing patients with high baseline calcium levels (> 700 mg/day) may not see an effect of calcium supplementation on blood pressure because of a ceiling effect. Supplemental calcium appears to correct a defect in calcium handling characterized by a renal calcium leak, increased circulating parathyroid hormone, and increased intracellular calcium levels. In part, the deficit in cellular calcium homeostasis may be a consequence of abnormal calmodulin activity. Specifically, it appears that calmodulin activity is diminished in experimental hypertension and that increasing dietary calcium may improve calmodulin activity in the spontaneously hypertensive rat. The deficit in calmodulin activity has the potential to interfere with a number of cellular processes crucial to the regulation of cell function and maintenance of appropriate vascular tone. It is concluded that additional research should be directed toward understanding the ramifications of altered calmodulin activity in hypertension and the influence that dietary calcium can have on the activity of calmodulin.",
keywords = "Ca metabolism, Calcium channel blockers, Calmodulin, Dietary Ca, Hypertension",
author = "McCarron, {D. A.} and D. Hatton and Jean-Baptiste Roullet and C. Roullet",
year = "1994",
language = "English (US)",
volume = "72",
pages = "937--944",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "8",

}

TY - JOUR

T1 - Dietary calcium, defective cellular Ca2+ handling, and arterial pressure control

AU - McCarron, D. A.

AU - Hatton, D.

AU - Roullet, Jean-Baptiste

AU - Roullet, C.

PY - 1994

Y1 - 1994

N2 - The association between dietary calcium intake, calcium metabolism, and blood pressure form the basis of this review. Epidemiologic data consistently show an inverse relationship between dietary calcium and blood pressure. Clinical trials of calcium supplementation have not been as consistent in outcome. Approximately two-thirds of the supplementation studies have found a beneficial effect of calcium on blood pressure. The lack of consistency in outcome from the clinical trials relative to the epidemiological literature may be related to calcium intake. The epidemiological literature indicates an inverse relationship between calcium intake and blood pressure, with those individuals with the lowest calcium intake (<700 mg/day) having the highest blood pressure. Clinical studies utilizing patients with high baseline calcium levels (> 700 mg/day) may not see an effect of calcium supplementation on blood pressure because of a ceiling effect. Supplemental calcium appears to correct a defect in calcium handling characterized by a renal calcium leak, increased circulating parathyroid hormone, and increased intracellular calcium levels. In part, the deficit in cellular calcium homeostasis may be a consequence of abnormal calmodulin activity. Specifically, it appears that calmodulin activity is diminished in experimental hypertension and that increasing dietary calcium may improve calmodulin activity in the spontaneously hypertensive rat. The deficit in calmodulin activity has the potential to interfere with a number of cellular processes crucial to the regulation of cell function and maintenance of appropriate vascular tone. It is concluded that additional research should be directed toward understanding the ramifications of altered calmodulin activity in hypertension and the influence that dietary calcium can have on the activity of calmodulin.

AB - The association between dietary calcium intake, calcium metabolism, and blood pressure form the basis of this review. Epidemiologic data consistently show an inverse relationship between dietary calcium and blood pressure. Clinical trials of calcium supplementation have not been as consistent in outcome. Approximately two-thirds of the supplementation studies have found a beneficial effect of calcium on blood pressure. The lack of consistency in outcome from the clinical trials relative to the epidemiological literature may be related to calcium intake. The epidemiological literature indicates an inverse relationship between calcium intake and blood pressure, with those individuals with the lowest calcium intake (<700 mg/day) having the highest blood pressure. Clinical studies utilizing patients with high baseline calcium levels (> 700 mg/day) may not see an effect of calcium supplementation on blood pressure because of a ceiling effect. Supplemental calcium appears to correct a defect in calcium handling characterized by a renal calcium leak, increased circulating parathyroid hormone, and increased intracellular calcium levels. In part, the deficit in cellular calcium homeostasis may be a consequence of abnormal calmodulin activity. Specifically, it appears that calmodulin activity is diminished in experimental hypertension and that increasing dietary calcium may improve calmodulin activity in the spontaneously hypertensive rat. The deficit in calmodulin activity has the potential to interfere with a number of cellular processes crucial to the regulation of cell function and maintenance of appropriate vascular tone. It is concluded that additional research should be directed toward understanding the ramifications of altered calmodulin activity in hypertension and the influence that dietary calcium can have on the activity of calmodulin.

KW - Ca metabolism

KW - Calcium channel blockers

KW - Calmodulin

KW - Dietary Ca

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=0028032532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028032532&partnerID=8YFLogxK

M3 - Article

VL - 72

SP - 937

EP - 944

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 8

ER -